UM  > 中華醫藥研究院
Fluorescence enhancement and p: K a shift of a rho kinase inhibitor by a synthetic receptor
Yin H.2; Chen L.2; Yang B.2; Bardelang D.1; Wang C.2; Lee S.M.Y.2; Wang R.2
2017
Source PublicationOrganic and Biomolecular Chemistry
ISSN14770520
Volume15Issue:20Pages:4336-4343
Abstract

Fasudil (FSD), a selective rho kinase (ROCK) inhibitor, was found to form 1:1 host-guest inclusion complexes with a synthetic macrocyclic receptor, cucurbit[7]uril (CB[7]), in aqueous solutions, as evidenced by H NMR, photoluminescence and UV-visible spectroscopic titrations, isothermal titration calorimetry (ITC) titration, and electrospray ionization (ESI) mass spectrometry, as well as density functional theory (DFT) molecular modeling. Upon encapsulation, whereas the UV-vis absorbance of FSD experienced a moderate decrease and bathochromic shift, the fluorescence intensity of FSD at 354 nm was dramatically enhanced for up to 69-fold at neutral pH, which could potentially be applied in fluorescent tracking of the drug delivery and release. More interestingly, the binding affinity (K = (4.28 ± 0.21) × 10 M), of FSD-CB[7] complexes under acidic conditions (pH = 2.0), is approximately three orders of magnitude higher than that (2.2∼6.6 × 10 M) under neutral pH conditions (pH = 7.0). Accordingly, UV-visible spectroscopic titration of the free and complexed FSD under various pH conditions has demonstrated that the encapsulation of FSD by CB[7] shifted the pK of the isoquinoline-N upward from 3.05 to 5.96 (ΔpK of 2.91). The significantly higher binding affinity of the complexes under acidic conditions may be applied in developing the "enteric" formulation of FSD. Furthermore, our in vitro study of the bioactivity of FSD in the absence and presence of CB[7] on a neural cell line, SH-SY5Y, showed that the complexation preserved the drug's pro-neurite efficacy. Thus this discovery may lead to a fluorescence-trackable, orally administered enteric formulation of rho kinase inhibitors that are stable under gastric conditions, without compromising bioactivity of the drugs.

DOI10.1039/c7ob00547d
URLView the original
Indexed BySCI
Language英语
WOS Research AreaChemistry
WOS SubjectChemistry, Organic
WOS IDWOS:000401944600012
Fulltext Access
Citation statistics
Cited Times [WOS]:5   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.Institut de Chimie Radicalaire
2.University of Macau
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
Yin H.,Chen L.,Yang B.,et al. Fluorescence enhancement and p: K a shift of a rho kinase inhibitor by a synthetic receptor[J]. Organic and Biomolecular Chemistry,2017,15(20):4336-4343.
APA Yin H..,Chen L..,Yang B..,Bardelang D..,Wang C..,...&Wang R..(2017).Fluorescence enhancement and p: K a shift of a rho kinase inhibitor by a synthetic receptor.Organic and Biomolecular Chemistry,15(20),4336-4343.
MLA Yin H.,et al."Fluorescence enhancement and p: K a shift of a rho kinase inhibitor by a synthetic receptor".Organic and Biomolecular Chemistry 15.20(2017):4336-4343.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Yin H.]'s Articles
[Chen L.]'s Articles
[Yang B.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Yin H.]'s Articles
[Chen L.]'s Articles
[Yang B.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Yin H.]'s Articles
[Chen L.]'s Articles
[Yang B.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.